Cipla arm secures marketing rights for cancer drug in US

Drug major Cipla today said its subsidiary has secured rights from Hyderabad-based MSN Laboratories to market and distribute colon cancer treatment drug Capecitabine in the US market.

Cipla USA, Inc, a subsidiary of the company will be marketing the drug in strengths of 150 and 500 mg tablets.

The company’s product is generic equivalent of Genentech’s Xeloda.

Capecitabine tablets are indicated in patients with colon cancer and for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy.

As per IQVIA (IMS Health) dat, Xeloda and its generic equivalents had sales of around USD 178 million in the US for 12-month period ending June 2018.

Shares of Cipla today ended 0.27 per cent up at Rs 620.90 on the BSE.

  • Related Posts

    • Pharma
    • June 20, 2025
    • 122 views
    Key supplier in alprazolam smuggling racket arrested in Uttar Pradesh

    The prime accused in a racket involving the unauthorised sale of alprazolam tablets across Andhra Pradesh and Telangana was traced to Kanpur, Uttar Pradesh by the Telangana Prohibition and Excise…

    • Pharma
    • June 20, 2025
    • 107 views
    Cough Syrup Smuggling Ring Busted in Bihar’s Samastipur; Two Women Among Seven Arrested

    Samastipur:  Police in the district have arrested seven individuals, including two women, for allegedly smuggling nearly 1,000 bottles of banned cough syrup containing narcotic substances. The seizure, made during a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Key supplier in alprazolam smuggling racket arrested in Uttar Pradesh

    Key supplier in alprazolam smuggling racket arrested in Uttar Pradesh

    Cough Syrup Smuggling Ring Busted in Bihar’s Samastipur; Two Women Among Seven Arrested

    Cough Syrup Smuggling Ring Busted in Bihar’s Samastipur; Two Women Among Seven Arrested

    Counterfeit cholesterol drugs worth Rs 3 lakh seized in raids at Koti

    Counterfeit cholesterol drugs worth Rs 3 lakh seized in raids at Koti

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product